Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ePoster Display

CN20 - Is bariatric surgery an effective method of reducing the risk of cancer in those who are obese?

Date

16 Sep 2021

Session

ePoster Display

Topics

Cancer Prevention

Tumour Site

Presenters

nidhi sharma

Citation

Annals of Oncology (2021) 32 (suppl_5): S1261-S1265. 10.1016/annonc/annonc692

Authors

N. sharma

Author affiliations

  • Medicine, University of Dundee, DD1 4HN - Dundee/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract CN20

Background

Obesity is a growing concern in the modern world and has now been recognised as the second most common risk factor for developing 13 types of cancers. Morbidity obesity is associated with life threating conditions, in such severe cases the treatment approach to weight loss is bariatric surgery following the strict guidelines in the UK.This literature review's aim is to assess clinical evidence on the effectiveness of bariatric surgery for reducing the risk of cancer in those who are obese.

Methods

Ten population-based cohort studies were analysed using criterion to provide evidence to the objective. The comparison is between obese patients undergone bariatric surgery and control group offered conservative treatment – behaviour modification therapy, lifestyle interventions or no treatment. Criteria included outcome measurements as relative risk of cancer (%) or the incidence of cancer (number of patients in each group). Exclusion criteria included foreign language papers, small sized population studies and patients with cancer history.

Results

Overall risk of developing cancer is significantly lower in patients who have undergone bariatric surgery compared to control patients. Obesity related cancers such as breast prostate, endometrium, kidney and oesophageal were significantly decreased in bariatric surgery patients compared to control group. Weight loss following bariatric surgery has been linked to reducing cancer in post-menopausal women. Mixed results were found on the association of colorectal cancer incidence in obese patients undergone bariatric surgery.

Conclusions

Bariatric surgery has decreased overall incidence of cancer, especially obesity-related cancer in obese patients. Women are more beneficial of surgery than men especially in terms of reducing hormone-related cancers (breast). Further investigations are required to understand the risk of colorectal cancer in patients undergone different types of bariatric surgery. Lastly, it would be recommended to keep a continuous follow-up to identify life-long incidence for cancer in post-surgery patients as various cancers take years to develop.

Clinical trial identification

Editorial acknowledgement

Annie Anderson (Teaching and Research) Population Health and Genomics, School of Medicine.

Legal entity responsible for the study

N. Sharma.

Funding

Has not received any funding.

Disclosure

The author has declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.